ASXL1 and chronic myelogenous leukemia, BCR-ABL1 positive: At diagnosis, mutations in ASXL1, DNMT3A, and TET2 dominated in CML-CP and RUNX1, IKZF1, and BCR::ABL1 in Ph+ ALL.